Therapy Areas: Vaccines
South Korea authorises use of Novavax's COVID-19 vaccine
12 January 2022 -

The South Korea food and drug safety ministry has authorised the use of US biotechnology company and vaccine developer Novavax Inc's (Nasdaq:NVAX) COVID-19 vaccine, Reuters news agency reported on Wednesday.

Vaccine developer SK Bioscience Co Ltd (KRX:302440) will produce the Novavax two-dose, protein-based vaccine for the country.

This vaccine has secured authorisations from European Union regulators and the World Health Organization. It has also been authorised in India, Indonesia and the Philippines.